✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Hindustan Bio Sciences Ltd.

HINDBIO

Market Cap
₹10 Cr.
P/E
94.49

Hindustan Bio Sciences Ltd.

  • Hind Bio Science
  • Beryl Drugs
  • Cian Healthcare
FAQs on Hindustan Bio Sciences Ltd. Shareprice

Hind Bio Science has given better returns compared to its competitors.
Hind Bio Science has grown at ~46.54% over the last 6yrs while peers have grown at a median rate of 14.93%

Hind Bio Science is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Hind Bio Science is 94.49, while 3 year average PE is 60.98.
Also latest EV/EBITDA of Hind Bio Science is 171 while 3yr average is 203.

View FAQ's On Business
Growth Table
  • Hindustan Bio Sciences Ltd.
  • Beryl Drugs
  • Cian Healthcare
Balance Sheet
  • Hindustan Bio Sciences Ltd.
  • Beryl Drugs
  • Cian Healthcare
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Hindustan Bio Sciences Ltd.
  • Beryl Drugs
  • Cian Healthcare
Cash Flow
  • Hindustan Bio Sciences Ltd.
  • Beryl Drugs
  • Cian Healthcare
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Hindustan Bio Sciences Ltd.
  • Beryl Drugs
  • Cian Healthcare
Quarterly Results
  • Hindustan Bio Sciences Ltd.
  • Beryl Drugs
  • Cian Healthcare
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Hindustan Bio Sciences Ltd. Financials

Hind Bio Science balance sheet is weak and might have solvency issues

Yes, The net debt of Hind Bio Science is increasing.
Latest net debt of Hind Bio Science is ₹2.49 Crs as of Mar-25.
This is greater than Mar-24 when it was ₹2.49 Crs.

Yes, profit is increasing.
The profit of Hind Bio Science is ₹0.06 Crs for Mar 2024, -₹0.04 Crs for Mar 2023 and -₹0.52 Crs for Mar 2022

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Hind Bio Science latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments, Short Term Loans & Advances

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech